CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 196978-197255 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1553","span":{"begin":0,"end":277},"obj":"Sentence"},{"id":"T26203","span":{"begin":0,"end":277},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the WHO guidelines (http://www.who.int/biologicals/publications/trs/ areas/vaccines/pneumo/en/index.html) the primary threshold for such trials is the proportion of subjects with antibody concentration of 0.35 mg/mL for all serotypes when measured via the WHO non-22F ELISA."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T18","span":{"begin":0,"end":277},"obj":"Sentence"}],"text":"In the WHO guidelines (http://www.who.int/biologicals/publications/trs/ areas/vaccines/pneumo/en/index.html) the primary threshold for such trials is the proportion of subjects with antibody concentration of 0.35 mg/mL for all serotypes when measured via the WHO non-22F ELISA."}